Showing results (61-70 of 100) with videos related to
Sort By:
Pageof 10
Antimicrobial Agents and Chemotherapy|June 1, 1992
Efficacy of erythromycin lactobionate for treating Pseudomonas aeruginosa bacteremia in miceY Hirakata, M Kaku, K Tomono, et al.Antimicrobial Agents and Chemotherapy|September 1, 1992
Potential effects of erythromycin on host defense systems and virulence of Pseudomonas aeruginosaY Hirakata, M Kaku, R Mizukane, et al.Japanese Circulation Journal|September 1, 1992
Spontaneous coronary artery dissection after a natural course for 10 years--a case reportJ Osaki, K Hirasawa, K Tateda, et al.Journal of Medical Microbiology|May 6, 1998
Effect of immunisation with Pseudomonas aeruginosa on gut-derived sepsis in miceT Matsumoto, K Tateda, S Miyazaki, et al.Journal of Medical Microbiology|May 6, 1998
Efficacies of alkaline protease, elastase and exotoxin A toxoid vaccines against gut-derived Pseudomonas aeruginosa sepsis in miceT Matsumoto, K Tateda, N Furuya, et al.Antimicrobial Agents and Chemotherapy|July 14, 1998
In vivo antibacterial activities of sanfetrinem cilexetil, a new oral tricyclic antibioticS Tamura, S Miyazaki, K Tateda, et al.Antimicrobial Agents and Chemotherapy|February 1, 1997
Immunomodulating effect of fosfomycin on gut-derived sepsis caused by Pseudomonas aeruginosa in miceT Matsumoto, K Tateda, S Miyazaki, et al.Infection and Immunity|January 1, 1991
Role of bacterial association with Kupffer cells in occurrence of endogenous systemic bacteremiaY Hirakata, K Tomono, K Tateda, et al.Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|March 1, 1992
[The study of pathogenic mechanisms of chronic Pseudomonas aeruginosa lung infections by mucoid strains]A Ohno, S Miyazaki, K Tateda, et al.Cytokine|November 5, 1997
Adverse effects of tumour necrosis factor in cyclophosphamide-treated mice subjected to gut-derived Pseudomonas aeruginosa sepsisT Matsumoto, K Tateda, S Miyazaki, et al.Pageof 10